BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/3/2026 6:28:03 AM | Browse: 51 | Download: 130
 |
Received |
|
2025-10-17 12:49 |
|
Peer-Review Started |
|
2025-10-17 12:55 |
|
First Decision by Editorial Office Director |
|
2025-10-22 06:43 |
|
Return for Revision |
|
2025-10-22 06:43 |
|
Revised |
|
2025-10-24 15:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-27 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-27 08:24 |
|
Articles in Press |
|
2025-11-27 08:24 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-26 05:58 |
|
Publish the Manuscript Online |
|
2026-02-03 06:28 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Advancing precision medicine in human epidermal growth factor receptor 2 negative gastric cancer: Insights from a novel nomogram for immunochemotherapy prognosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abinash Nayak, Gunanidhi Sahoo and Sudhansu Sekhar Nishank |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abinash Nayak, Academic Fellow, Assistant Professor, Lecturer, Research Fellow, Researcher, Post-graduate Department of Zoology, Utkal University, Vani Vihar, Bhubaneshwar 751004, Odisha, India. abinashnayakzoology@gmail.com |
| Key Words |
Gastric cancer; Human epidermal growth factor receptor 2; Immunochemotherapy; Nomogram; Prognostic model; Biomarkers; Precision oncology |
| Core Tip |
The nomogram by Yao et al represents a comprehensive tool for prognosticating outcomes in advanced human epidermal growth factor receptor 2-negative gastric cancer patients on immunochemotherapy. By incorporating immune, clinicopathological, and inflammatory markers, it achieves high discriminative power. Recent advancements in circulatory tumor DNA, artificial intelligence-radiomics, and combination therapies like claudin 18.2-targeting complement this model, highlighting the need for prospective validation to enhance clinical utility. |
| Publish Date |
2026-02-03 06:28 |
| Citation |
Nayak A, Sahoo G, Nishank SS. Advancing precision medicine in human epidermal growth factor receptor 2 negative gastric cancer: Insights from a novel nomogram for immunochemotherapy prognosis. World J Gastrointest Oncol 2026; 18(2): 115401 |
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i2/115401.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v18.i2.115401 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
